HEADER STRUCTURAL PROTEIN 18-APR-05 2BP3 TITLE CRYSTAL STRUCTURE OF FILAMIN A DOMAIN 17 AND GPIB ALPHA CYTOPLASMIC TITLE 2 DOMAIN COMPLEX COMPND MOL_ID: 1; COMPND 2 MOLECULE: FILAMIN A; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: ROD DOMAIN, RESIDUES 1863-1956; COMPND 5 SYNONYM: ALPHA-FILAMIN, FILAMIN 1, ENDOTHELIAL ACTIN-BINDING PROTEIN, COMPND 6 ACTIN-BINDING PROTEIN 280, ABP-280, NONMUSCLE FILAMIN; COMPND 7 ENGINEERED: YES; COMPND 8 MOL_ID: 2; COMPND 9 MOLECULE: PLATELET GLYCOPROTEIN IB ALPHA CHAIN; COMPND 10 CHAIN: S, T; COMPND 11 FRAGMENT: CYTOPLASMIC DOMAIN, RESIDUES 572-593; COMPND 12 SYNONYM: GLYCOPROTEIN B ALPHA, GLYCOPROTEIN IBALPHA, GP-IB ALPHA, COMPND 13 GPIBA, GPIB-ALPHA, CD42B-ALPHA, CD42B; COMPND 14 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 511693; SOURCE 7 EXPRESSION_SYSTEM_STRAIN: BL21; SOURCE 8 EXPRESSION_SYSTEM_PLASMID: PGEX4T-3; SOURCE 9 MOL_ID: 2; SOURCE 10 SYNTHETIC: YES; SOURCE 11 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 12 ORGANISM_COMMON: HUMAN; SOURCE 13 ORGANISM_TAXID: 9606 KEYWDS STRUCTURAL PROTEIN, CYTOSKELETON-COMPLEX, ACTIN BINDING PROTEIN, KEYWDS 2 CYTOSKELETON, COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR R.PUDAS,J.YLANNE REVDAT 4 13-DEC-23 2BP3 1 REMARK REVDAT 3 24-FEB-09 2BP3 1 VERSN REVDAT 2 01-MAR-06 2BP3 1 JRNL REVDAT 1 30-NOV-05 2BP3 0 JRNL AUTH F.NAKAMURA,R.PUDAS,O.HEIKKINEN,P.PERMI,I.KILPELAINEN, JRNL AUTH 2 A.D.MUNDAY,J.H.HARTWIG,T.P.STOSSEL,J.YLANNE JRNL TITL THE STRUCTURE OF THE GPIB-FILAMIN A COMPLEX. JRNL REF BLOOD V. 107 1925 2006 JRNL REFN ISSN 0006-4971 JRNL PMID 16293600 JRNL DOI 10.1182/BLOOD-2005-10-3964 REMARK 2 REMARK 2 RESOLUTION. 2.32 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.2.0005 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.32 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 19.88 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 3 NUMBER OF REFLECTIONS : 12211 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.216 REMARK 3 R VALUE (WORKING SET) : 0.214 REMARK 3 FREE R VALUE : 0.256 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 645 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.31 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.38 REMARK 3 REFLECTION IN BIN (WORKING SET) : 503 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 100.0 REMARK 3 BIN R VALUE (WORKING SET) : 0.2560 REMARK 3 BIN FREE R VALUE SET COUNT : 27 REMARK 3 BIN FREE R VALUE : 0.3010 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 1553 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 12 REMARK 3 SOLVENT ATOMS : 28 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 57.94 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -2.78000 REMARK 3 B22 (A**2) : 4.30000 REMARK 3 B33 (A**2) : -1.52000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.263 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.217 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.147 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 5.978 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.940 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.920 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 1600 ; 0.012 ; 0.022 REMARK 3 BOND LENGTHS OTHERS (A): NULL ; NULL ; NULL REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 2181 ; 1.463 ; 1.974 REMARK 3 BOND ANGLES OTHERS (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 204 ; 6.753 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 59 ;35.701 ;23.559 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 227 ;19.462 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 7 ;19.175 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 248 ; 0.097 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 1223 ; 0.005 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): 570 ; 0.219 ; 0.200 REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): 1037 ; 0.309 ; 0.200 REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): 70 ; 0.128 ; 0.200 REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): 33 ; 0.251 ; 0.200 REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): 4 ; 0.198 ; 0.200 REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 1056 ; 2.655 ; 4.000 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 1674 ; 4.170 ; 6.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 609 ; 3.095 ; 4.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 507 ; 4.346 ; 6.000 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : BABINET MODEL WITH MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS. FLEXIBLE SIDE CHAINS OF SOME RESIDUES LOCATED IN THE REMARK 3 LOOP REGIONS COULD NOT BE BUILD USING AVAILABLE DENSITY AND REMARK 3 THESE RESIDUES WERE MODELED: A 1881 ASN, A 1882 LYS, A 1892 ASP, REMARK 3 A 1916 GLN, B 1891 LYS, B 1892 ASP, B 1909 GLU, B 1916 GLN, B REMARK 3 1917 ASP REMARK 4 REMARK 4 2BP3 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 18-APR-05. REMARK 100 THE DEPOSITION ID IS D_1290023647. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 05-DEC-04 REMARK 200 TEMPERATURE (KELVIN) : 100.0 REMARK 200 PH : 8.20 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ESRF REMARK 200 BEAMLINE : ID23-1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9795 REMARK 200 MONOCHROMATOR : SILICON (1 1 1) CHANNEL-CUT REMARK 200 OPTICS : TOROIDAL MIRROR REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARRESEARCH REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XDS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 12876 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.320 REMARK 200 RESOLUTION RANGE LOW (A) : 19.880 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 86.9 REMARK 200 DATA REDUNDANCY : 6.000 REMARK 200 R MERGE (I) : 0.09000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 14.0000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.31 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.45 REMARK 200 COMPLETENESS FOR SHELL (%) : 56.7 REMARK 200 DATA REDUNDANCY IN SHELL : 3.70 REMARK 200 R MERGE FOR SHELL (I) : 0.53000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 3.130 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: PDB ENTRY 1V05 REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 65.78 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.62 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 1.75M AMMONIUM PHOSPHATE, PH 8.2, REMARK 280 AFTER MICROSEEDING: 1.25M AMMONIUM SULFATE PH 8.2, PH 8.20 REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 20.95000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 61.40000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 31.40000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 61.40000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 20.95000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 31.40000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PQS REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, T REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PQS REMARK 350 APPLY THE FOLLOWING TO CHAINS: B, S REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A -3 REMARK 465 ALA A -2 REMARK 465 GLY A 1866 REMARK 465 ASP A 1956 REMARK 465 GLY B -3 REMARK 465 ALA B -2 REMARK 465 MET B -1 REMARK 465 VAL B 1863 REMARK 465 ASN B 1864 REMARK 465 ASP B 1956 REMARK 465 LEU S 556 REMARK 465 ARG S 557 REMARK 465 GLY S 558 REMARK 465 SER S 559 REMARK 465 LEU S 560 REMARK 465 PRO S 561 REMARK 465 ASN S 574 REMARK 465 GLY S 575 REMARK 465 ARG S 576 REMARK 465 VAL S 577 REMARK 465 LEU T 556 REMARK 465 GLY T 575 REMARK 465 ARG T 576 REMARK 465 VAL T 577 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 MET A -1 CG SD CE REMARK 470 VAL A1863 CG1 CG2 REMARK 470 ASN A1864 CG OD1 ND2 REMARK 470 CYS A1865 CA C O CB SG REMARK 470 ASP A1955 CA C O CB CG OD1 OD2 REMARK 470 ASP B1955 CA C O CB CG OD1 OD2 REMARK 470 PRO S 573 CA C O CB CG CD REMARK 470 ASN T 574 CA C O CB CG OD1 ND2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 GLN A1916 -8.47 75.22 REMARK 500 GLN B1916 -1.68 71.82 REMARK 500 REMARK 500 REMARK: NULL REMARK 700 REMARK 700 SHEET REMARK 700 THE SHEET STRUCTURE OF THIS MOLECULE IS BIFURCATED. IN REMARK 700 ORDER TO REPRESENT THIS FEATURE IN THE SHEET RECORDS BELOW, REMARK 700 TWO SHEETS ARE DEFINED. REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GOL A2955 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GOL B2955 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1GWB RELATED DB: PDB REMARK 900 STRUCTURE OF GLYCOPROTEIN 1B REMARK 900 RELATED ID: 1K13 RELATED DB: PDB REMARK 900 SEVEN TANDEM LEUCINE-RICH REPEATS OF HUMAN GLYCOPROTEIN 1BALPHA REMARK 900 RELATED ID: 1M0Z RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE VON WILLEBRAND FACTOR BINDINGDOMAIN OF REMARK 900 GLYCOPROTEIN IB ALPHA REMARK 900 RELATED ID: 1M10 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE COMPLEX OF GLYCOPROTEIN IB ALPHAAND THE REMARK 900 VON WILLEBRAND FACTOR A1 DOMAIN REMARK 900 RELATED ID: 1OOK RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE COMPLEX OF PLATELET RECEPTOR GPIB-ALPHA REMARK 900 AND HUMAN ALPHA- THROMBIN REMARK 900 RELATED ID: 1P8V RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE COMPLEX OF PLATELET RECEPTOR GPIB-ALPHA REMARK 900 AND ALPHA-THROMBIN AT 2.6A REMARK 900 RELATED ID: 1P9A RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF N-TERMINAL DOMAIN OF HUMAN PLATELETRECEPTOR REMARK 900 GLYCOPROTEIN IB-ALPHA AT 1.7 ANGSTROM RESOLUTION REMARK 900 RELATED ID: 1QYY RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF N-TERMINAL DOMAIN OF HUMAN PLATELETRECEPTOR REMARK 900 GLYCOPROTEIN IB-ALPHA AT 2.8 ANGSTROM RESOLUTION REMARK 900 RELATED ID: 1SQ0 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE COMPLEX OF THE WILD-TYPE VONWILLEBRAND REMARK 900 FACTOR A1 DOMAIN AND GLYCOPROTEIN IB ALPHA AT2.6 ANGSTROM RESOLUTION REMARK 900 RELATED ID: 2BRQ RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE FILAMIN A REPEAT 21 COMPLEXED WITH THE REMARK 900 INTEGRIN BETA7 CYTOPLASMIC TAIL PEPTIDE REMARK 999 REMARK 999 SEQUENCE REMARK 999 THE THREE N-TERMINAL RESIDUES OF CHAINS A AND B ARE REMARK 999 FROM THE EXPRESSION VECTOR. DBREF 2BP3 A -3 -1 PDB 2BP3 2BP3 -3 -1 DBREF 2BP3 A 1863 1956 UNP P21333 FLNA_HUMAN 1863 1956 DBREF 2BP3 B -3 -1 PDB 2BP3 2BP3 -3 -1 DBREF 2BP3 B 1863 1956 UNP P21333 FLNA_HUMAN 1863 1956 DBREF 2BP3 S 556 577 UNP P07359 GP1BA_HUMAN 572 593 DBREF 2BP3 T 556 577 UNP P07359 GP1BA_HUMAN 572 593 SEQRES 1 A 97 GLY ALA MET VAL ASN CYS GLY HIS VAL THR ALA TYR GLY SEQRES 2 A 97 PRO GLY LEU THR HIS GLY VAL VAL ASN LYS PRO ALA THR SEQRES 3 A 97 PHE THR VAL ASN THR LYS ASP ALA GLY GLU GLY GLY LEU SEQRES 4 A 97 SER LEU ALA ILE GLU GLY PRO SER LYS ALA GLU ILE SER SEQRES 5 A 97 CYS THR ASP ASN GLN ASP GLY THR CYS SER VAL SER TYR SEQRES 6 A 97 LEU PRO VAL LEU PRO GLY ASP TYR SER ILE LEU VAL LYS SEQRES 7 A 97 TYR ASN GLU GLN HIS VAL PRO GLY SER PRO PHE THR ALA SEQRES 8 A 97 ARG VAL THR GLY ASP ASP SEQRES 1 B 97 GLY ALA MET VAL ASN CYS GLY HIS VAL THR ALA TYR GLY SEQRES 2 B 97 PRO GLY LEU THR HIS GLY VAL VAL ASN LYS PRO ALA THR SEQRES 3 B 97 PHE THR VAL ASN THR LYS ASP ALA GLY GLU GLY GLY LEU SEQRES 4 B 97 SER LEU ALA ILE GLU GLY PRO SER LYS ALA GLU ILE SER SEQRES 5 B 97 CYS THR ASP ASN GLN ASP GLY THR CYS SER VAL SER TYR SEQRES 6 B 97 LEU PRO VAL LEU PRO GLY ASP TYR SER ILE LEU VAL LYS SEQRES 7 B 97 TYR ASN GLU GLN HIS VAL PRO GLY SER PRO PHE THR ALA SEQRES 8 B 97 ARG VAL THR GLY ASP ASP SEQRES 1 S 22 LEU ARG GLY SER LEU PRO THR PHE ARG SER SER LEU PHE SEQRES 2 S 22 LEU TRP VAL ARG PRO ASN GLY ARG VAL SEQRES 1 T 22 LEU ARG GLY SER LEU PRO THR PHE ARG SER SER LEU PHE SEQRES 2 T 22 LEU TRP VAL ARG PRO ASN GLY ARG VAL HET GOL A2955 6 HET GOL B2955 6 HETNAM GOL GLYCEROL HETSYN GOL GLYCERIN; PROPANE-1,2,3-TRIOL FORMUL 5 GOL 2(C3 H8 O3) FORMUL 7 HOH *28(H2 O) HELIX 1 1 GLY A 1872 LEU A 1875 5 4 HELIX 2 2 GLY B 1872 LEU B 1875 5 4 SHEET 1 AA 4 THR A1869 TYR A1871 0 SHEET 2 AA 4 ALA A1884 ASN A1889 -1 O THR A1887 N TYR A1871 SHEET 3 AA 4 THR A1919 LEU A1925 -1 O CYS A1920 N VAL A1888 SHEET 4 AA 4 GLU A1909 ASP A1914 -1 O GLU A1909 N LEU A1925 SHEET 1 AB 5 HIS A1877 VAL A1879 0 SHEET 2 AB 5 PHE A1948 THR A1953 1 O ARG A1951 N GLY A1878 SHEET 3 AB 5 GLY A1930 TYR A1938 -1 O GLY A1930 N VAL A1952 SHEET 4 AB 5 GLY A1896 GLY A1904 -1 O SER A1899 N LYS A1937 SHEET 5 AB 5 PHE T 563 VAL T 571 -1 O PHE T 563 N GLY A1904 SHEET 1 AC 4 HIS A1877 VAL A1879 0 SHEET 2 AC 4 PHE A1948 THR A1953 1 O ARG A1951 N GLY A1878 SHEET 3 AC 4 GLY A1930 TYR A1938 -1 O GLY A1930 N VAL A1952 SHEET 4 AC 4 GLN A1941 HIS A1942 -1 O GLN A1941 N TYR A1938 SHEET 1 BA 4 THR B1869 TYR B1871 0 SHEET 2 BA 4 ALA B1884 ASN B1889 -1 O THR B1887 N TYR B1871 SHEET 3 BA 4 THR B1919 LEU B1925 -1 O CYS B1920 N VAL B1888 SHEET 4 BA 4 GLU B1909 ASP B1914 -1 O GLU B1909 N LEU B1925 SHEET 1 BB 5 HIS B1877 VAL B1879 0 SHEET 2 BB 5 PHE B1948 THR B1953 1 O ARG B1951 N GLY B1878 SHEET 3 BB 5 GLY B1930 TYR B1938 -1 O GLY B1930 N VAL B1952 SHEET 4 BB 5 GLY B1896 GLY B1904 -1 O SER B1899 N LYS B1937 SHEET 5 BB 5 PHE S 563 VAL S 571 -1 O PHE S 563 N GLY B1904 SHEET 1 BC 4 HIS B1877 VAL B1879 0 SHEET 2 BC 4 PHE B1948 THR B1953 1 O ARG B1951 N GLY B1878 SHEET 3 BC 4 GLY B1930 TYR B1938 -1 O GLY B1930 N VAL B1952 SHEET 4 BC 4 GLN B1941 HIS B1942 -1 O GLN B1941 N TYR B1938 CISPEP 1 SER A 1946 PRO A 1947 0 -2.11 CISPEP 2 SER B 1946 PRO B 1947 0 10.79 SITE 1 AC1 8 THR A1890 ALA A1893 GLY A1894 GLY A1918 SITE 2 AC1 8 ASN B1939 GLU B1940 VAL T 571 PRO T 573 SITE 1 AC2 3 LYS A1891 GLN B1941 HOH B2010 CRYST1 41.900 62.800 122.800 90.00 90.00 90.00 P 21 21 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.023866 0.000000 0.000000 0.00000 SCALE2 0.000000 0.015924 0.000000 0.00000 SCALE3 0.000000 0.000000 0.008143 0.00000